Nadolol: Clinical Trials

19 trials of Nadolol, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

15 completed, 2 unknown, 1 recruiting, 1 withdrawn. 7 Phase 4, 5 Phase 2, 4 Phase 1, 2 Phase 3, 1 Early Phase 1.

By phase and status

PhaseTrialsStatus
Phase 47Completed 6, Unknown 1
Phase 25Completed 4, Unknown 1
Phase 14Completed 4
Phase 32Completed 1, Withdrawn 1
Early Phase 11Recruiting 1

Follow Nadolol: new trials by email Literature Review of Nadolol trials Research Report on Nadolol

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study of Clenbuterol (CST-103) Co-administered With Nadolol (CST-107) in Subjects With Neurodegenerative Disorders
clenbuterol (CST-103), nadolol (CST-107), matching placebo - Mild Cognitive Impairment, Lewy Body Dementia, Parkinson's Disease Rapid Eye Movement Sleep Behavior Disorder, Parkinson's Disease Dementia
Phase 2CompletedCuraSen Therapeutics, Inc.412021-06-282024-12-02
Impact of Beta-blockers on Physical Function in HFpEF
Beta blockers - Heart Failure, Heart Failure, Diastolic
Phase 4CompletedWeill Medical College of Cornell University92021-04-012023-09-08
Pilot Deprescribing N-of-1 Trials for Beta-blockers in HFpEF
Beta blockers - Heart Failure, Heart Failure, Diastolic
Phase 4CompletedWeill Medical College of Cornell University92021-04-012024-04-09
ACEI or ARB and COVID-19 Severity and Mortality in US Veterans
ACEI/ARB, Non-ACEI/ARB, ACEI - Hypertension, COVID
CompletedUniversity of Utah222132020-01-192021-04-28
Exercise as an Immune Adjuvant for Allogeneic Cell Therapies
Exercise, Isoproterenol, Placebo - Leukemia, Hematopoetic Stem Cell Transplantation
Early Phase 1RecruitingUniversity of Arizona2002018-01-242026-06-05
Nadolol Versus Propranolol in Children With Infantile Hemangiomas
Nadolol, Propranolol - Infantile Hemangioma
Phase 3CompletedThe Hospital for Sick Children742015-09-012020-10-28
Efficacy and Safety of Βeta-adrenoceptor Inverse Agonist and Biased Ligand, Nadolol, In Smoking Cessation of Patients With Chronic Cough With or Without Airflow Obstruction
Nadolol, Placebo - Smoking Cessation
Phase 2CompletedInvion, Inc.1552014-03-012017-02-01
Efficacy and Safety of Beta-adrenoceptor Inverse Agonist, Nadolol, in Mild Asthma
Nadolol, Placebo - Mild Persistent Asthma, Uncomplicated
Phase 2UnknownInvion, Inc.602013-03-012016-08-09
Nadolol for Proliferating Infantile Hemangiomas
Nadolol - Infantile Hemangioma
Phase 2CompletedThe Hospital for Sick Children202009-11-012021-08-19
Endoscopic Cyanoacrylate Obliteration vs. Nadolol Treatment in the Prevention of Gastric Variceal Rebleeding
Nadolol - Liver Cirrhosis and Hepatoma., Gastric Variceal Bleeding
Phase 4UnknownTaipei Veterans General Hospital, Taiwan1202007-04-012010-06-08
Oral Nadolol for the Treatment of Adults With Mild Asthma
nadolol - Asthma
Phase 1 / Phase 2CompletedInvion, Inc.102007-01-012016-05-11
Fed Study of Nadolol/Bendroflumethiazide Tablets 80 mg/5 mg and Corzide® Tablets 80 mg/5 mg
Nadolol/Bendroflumethiazide Tablets 80 mg/5 mg, Corzide® Tablets 80 mg/5 mg - Healthy
Phase 1CompletedMylan Pharmaceuticals Inc422006-08-012024-04-23
Fasting Study of Nadolol/Bendroflumethiazide Tablets 80 mg/5 mg and Corzide® Tablets 80 mg/5 mg
Nadolol/Bendroflumethiazide Tablets 80 mg/5 mg, Corzide® Tablets 80 mg/5 mg - Healthy
Phase 1CompletedMylan Pharmaceuticals Inc662006-07-012024-04-23
Secondary Prophylaxis of Gastrointestinal Bleeding in Cirrhotic Patients Using THALIDOMIDE
Thalidomide - Gastrointestinal Hemorrhage, Portal Hypertension
Phase 3WithdrawnThe Cleveland Clinic2006-05-012013-07-31
A Trial of Nadolol Plus Isosorbide Mononitrate Versus Carvedilol for the Prevention of Variceal Rebleeding
carvedilol, nadolol + ISMN - Variceal Rebleeding
Phase 4CompletedE-DA Hospital1212005-03-012010-10-26
A Trial of Ligation Plus Nadolol Versus Nadolol Alone in the Prophylaxis of First Variceal Bleeding in Cirrhosis
Ligation of varices, Nadolol - Variceal Bleeding, Cirrhosis
Phase 4CompletedNational Science and Technology Council, Taiwan1402004-12-012009-06-16
Drug and Non-Drug Treatment Of Severe Migraine
Propranolol or nadolol, Placebo control, Behavioral Migraine Management (BMM) - Migraine Headache
Phase 4CompletedOhio University2322001-07-012016-11-22
Secondary Prophylaxis After Variceal Bleeding in Non-Responders
esofagic varices ligation, Nadolol, Isosorbide mononitrate - Gastrointestinal Hemorrhage, Portal Hypertension
Phase 4CompletedFundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau502000-11-012007-03-21
Relative Bioavailability Study of Nadolol (1 x 80 mg) Tablets Under Fasting Conditions
Nadolol (1 x 80 mg) Tablets (Invamed, Inc), Corgard (1 x 80 mg) Tablets (Bristol Laboratories) - High Blood Pressure, Migraine Headaches
Phase 1CompletedSandoz341994-07-012017-03-28

Conditions studied

Fibrosis (3)  ·  Gastrointestinal Hemorrhage (2)  ·  Heart Diseases (2)  ·  Heart Failure (2)  ·  Heart Failure, Diastolic (2)  ·  Hemangioma, Capillary (2)  ·  Hypertension (2)  ·  Hypertension, Portal (2)  ·  Migraine Disorders (2)  ·  Asthma (1)  ·  Carcinoma, Hepatocellular (1)  ·  Chest Pain (1)  ·  Cognitive Dysfunction (1)  ·  Hemangioma (1)  ·  Leukemia (1)

Sponsors

Invion, Inc. (3)  ·  Mylan Pharmaceuticals Inc (2)  ·  The Hospital for Sick Children (2)  ·  Weill Medical College of Cornell University (2)  ·  CuraSen Therapeutics, Inc. (1)  ·  E-DA Hospital (1)  ·  Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau (1)  ·  National Science and Technology Council, Taiwan (1)  ·  Ohio University (1)  ·  Sandoz (1)  ·  Taipei Veterans General Hospital, Taiwan (1)  ·  The Cleveland Clinic (1)  ·  University of Arizona (1)  ·  University of Utah (1)

Countries

United States (11)  ·  Canada (2)  ·  Australia (1)  ·  China (1)  ·  New Zealand (1)  ·  Spain (1)  ·  United Kingdom (1)

Top investigators

James D Carlson, Pharm. D. (2)  ·  Parag Goyal, MD (2)  ·  Adam P Bress, PharmD, MS (1)  ·  Elena Pope, MD (1)  ·  Elena Pope, MD, MSc (1)  ·  Kenneth A Holroyd, Ph.D. (1)  ·  Mario Castro, M.D. (1)  ·  Ming-Chih Hou, MD (1)  ·  Nicola A Hanania, MD (1)  ·  Nicola A. Hanania, MD, MS (1)  ·  Terry L. Wolff, D.O. (1)

Results publications

PMID 20880898, PMID 33891615, PMID 34747977, PMID 36189306, PMID 36719647, PMID 37077913, PMID 38592213, PMID 40311885, PMID 40574863, PMID 40940923, PMID 41194247, PMID 41538301, PMID 41776652, PMID 42845554

NIH funding

K76AG064428 (1), R01CA277493 (1)